《抗肿瘤药物治疗期间肾损伤管理临床实践指南（2022）》解读（四）：肾损伤患者抗肿瘤药物的剂量调整（第1部分）
PDF(1034 KB)
《抗肿瘤药物治疗期间肾损伤管理临床实践指南（2022）》解读（四）：肾损伤患者抗肿瘤药物的剂量调整（第1部分）
陈喆1，郑茜子2，周庆庆2，李国辉1Interpretation of Clinical Practice Guidelines for Management of Kidney Injury During Anticancer Drug Therapy 2022 (Ⅳ): dose adjustment of anticancer drug in patients with impaired kidney function (Part 1)
Chen Zhe1, Zheng Xizi2, Zhou Qingqing2, Li Guohui1Author information+
History+
摘要
肾功能不全患者由于肾脏的排泄功能下降或延迟以及与肾功能下降相关的药物代谢动力学改变，可能导致药物或其代谢物在体内蓄积，药物不良反应发生的风险增加。因此，肾功能不全患者在进行抗肿瘤药物治疗时需要调整药物剂量。日本肾脏病学会、日本临床肿瘤学会、日本医学肿瘤学会和日本肾脏病药物治疗学会共同制订的《抗肿瘤药物治疗期间肾损伤管理临床实践指南
（2022）》的第二章中专门论述了肾损伤患者抗肿瘤药物的剂量调整。本文重点解读该章节中肾功能不全患者药物剂量调整的原则和铂类药物、氟尿嘧啶类药物的剂量调整建议。
Abstract
Accumulation of drugs and its metabolites in the body occurs and risks of adverse drugreactions increase in renal insufficiency patients due to the renal function decline or delay of renal excretionand the pharmacokinetic changes related to the decline of renal function. Therefore, the dose of anticancerdrugs should be adjusted in tumor patients with renal dysfunction. The Japanese Society of Nephrology,JapanSociety of Clinical Oncology,Japanese Society ofMedical Oncology,and Japanese Society of Nephrologyand Pharmacotherapy have jointly formulated Clinical Practice Guidelines for Management of Kidney Injury During Anticancer Drug Therapy 2022, and specifically discusses the dose adjustment of anticancer drug forpatients with renal injury in the second chapter. This article focuses on the interpretation of the principle ofdrug dose adjustment for patients with renal insufficiency and suggestions for dose adjustment of platinumdrugs and fluorouracil drugs in this chapter.
关键词
抗肿瘤药物；肾功能不全 /慢性；慢性肾脏病；药物剂量调整；指南；解读 {{custom_keyword}} /
Key words
Antineoplastic agents /Renal insufficiency, chronic /Chronic kidney disease /Drug dose adjustment /Guideline /Interpretation{{custom_keyword}} /
陈喆, 郑茜子, 周庆庆, 李国辉.《抗肿瘤药物治疗期间肾损伤管理临床实践指南（2022）》解读（四）：肾损伤患者抗肿瘤药物的剂量调整（第1部分）. 药物不良反应杂志. 2024, 26(8): 449-453 https://doi.org/10.3760/cma.j.cn114015‑20240603‑00413
Chen Zhe, Zheng Xizi, Zhou Qingqing, Li Guohui.Interpretation of Clinical Practice Guidelines for Management of Kidney Injury During Anticancer Drug Therapy 2022 (Ⅳ): dose adjustment of anticancer drug in patients with impaired kidney function (Part 1). Adverse Drug Reactions Journal. 2024, 26(8): 449-453 https://doi.org/10.3760/cma.j.cn114015‑20240603‑00413
PDF(1034 KB)
相关知识
铁树花怎么吃可以抗肿瘤
毛蕊花糖苷联合抗癌治疗剂在医药上的应用及药物组合物
一棵珍稀小草因何能够集抗肿瘤、抗病毒、增强免疫、健脾益气为一体？
长期失眠，药物性肝损伤
“肿瘤肺炎共识”发布：聚焦实体肿瘤患者伴发肺炎管理新标准，助力肿瘤患者全程诊疗
补肾不如护肾，你是如何养护肾的呢？警惕肾脏四大求救信号！
养花治疗精神病的药物
长春花——绽放在医学领域的抗癌之花
花类药食同源中药，都给你整理好了
免疫增强药物及免疫增强疗法
网址: 《抗肿瘤药物治疗期间肾损伤管理临床实践指南（2022）》解读（四）：肾损伤患者抗肿瘤药物的剂量调整（第1部分） https://m.huajiangbk.com/newsview349469.html
| 上一篇: ESMO 2024丨ADRIAT |
下一篇: 武汉市第一医院 |
